Lars Thomander
Corporate Officer/Principal at University of Uppsala
Lars Thomander active positions
| Companies | Position | Start | End |
|---|---|---|---|
| University of Uppsala | Corporate Officer/Principal | - | - |
Career history of Lars Thomander
Former positions of Lars Thomander
| Companies | Position | Start | End |
|---|---|---|---|
| Abbott Scandinavia AB | Chief Tech/Sci/R&D Officer | 2008-12-31 | 2012-12-31 |
AbbVie AB
 AbbVie AB Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie AB is a clinical research and development pharmaceutical company. The company is based in Solna, Sweden. AbbVie was founded in 2013 and operates in the pharmaceutical industry, focusing on research and development. | Chief Tech/Sci/R&D Officer | 2008-12-31 | 2012-12-31 |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | - | - |
| Foundation for Pharmaceutical Medicine | Director/Board Member | - | - |
| Swedish Pharmaceutical Society | President | - | - |
| Hlt Konsult AB | Director/Board Member | - | - |
| Founder | - | - | |
CaptiGel AB
 CaptiGel AB BiotechnologyHealth Technology CaptiGel AB provides patented technological platform for encapsulation and controlled release of biomolecules and microorganisms. It offers a technology based on eco-friendly and commonly used raw materials, which will provide protective capabilities of the encapsulated material. The company was founded Vadim Kessler, Gulaim Seisenbaeva, Maria Unell, and Sebastian Håkansson in 2009 and is headquartered in Uppsala, Sweden. | Chairman | 2013-12-31 | - |
Double Bond Pharmaceutical International AB
 Double Bond Pharmaceutical International AB BiotechnologyHealth Technology Double Bond Pharmaceutical International AB is a pharmaceutical company, which engages in developing and commercializing approaches for treatment of cancers, infections, autoimmune diseases, and life-threatening disorders. It also involves in designing medicinal products for patients suffering from diseases such as cancer, inflammation, asthma or diabetes. The company was founded on November 21, 2014 and is headquartered in Uppsala, Sweden. | Director/Board Member | 2015-03-31 | - |
Statistics
International
| Sweden | 9 |
| United States | 2 |
Operational
| Director/Board Member | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chairman | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
 | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Private companies | 6 |
|---|---|
CaptiGel AB
CaptiGel AB BiotechnologyHealth Technology CaptiGel AB provides patented technological platform for encapsulation and controlled release of biomolecules and microorganisms. It offers a technology based on eco-friendly and commonly used raw materials, which will provide protective capabilities of the encapsulated material. The company was founded Vadim Kessler, Gulaim Seisenbaeva, Maria Unell, and Sebastian Håkansson in 2009 and is headquartered in Uppsala, Sweden. | Health Technology |
| Hlt Konsult AB | |
| Abbott Scandinavia AB | |
AbbVie AB
AbbVie AB Miscellaneous Commercial ServicesCommercial Services Part of AbbVie, Inc., AbbVie AB is a clinical research and development pharmaceutical company. The company is based in Solna, Sweden. AbbVie was founded in 2013 and operates in the pharmaceutical industry, focusing on research and development. | Commercial Services |
| Swedish Pharmaceutical Society | |
| Foundation for Pharmaceutical Medicine |
- Stock Market
- Insiders
- Lars Thomander
- Experience
